383 related articles for article (PubMed ID: 3023591)
1. Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats.
Moursi MG; Ganten D; Lang RE; Unger T
J Hypertens Suppl; 1986 Oct; 4(3):S495-8. PubMed ID: 3023591
[TBL] [Abstract][Full Text] [Related]
2. [Antihypertensive action and inhibition of tissue conversion enzyme by ramipril, perindopril and enalapril in the spontaneously hypertensive rat (SHRSP)].
Unger T; Moursi MG; Lebrun C; Ganten D; Lang RE
Arch Mal Coeur Vaiss; 1986 Jun; 79(6):971-4. PubMed ID: 3026275
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive action of the converting enzyme inhibitor perindopril (S9490-3) in spontaneously hypertensive rats: comparison with enalapril (MK421) and ramipril (Hoe498).
Unger T; Moursi M; Ganten D; Hermann K; Lang RE
J Cardiovasc Pharmacol; 1986; 8(2):276-85. PubMed ID: 2422465
[TBL] [Abstract][Full Text] [Related]
4. 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498): antihypertensive action and persistent inhibition of tissue converting enzyme activity in spontaneously hypertensive rats.
Unger T; Fleck T; Ganten D; Lang RE; Rettig F
Arzneimittelforschung; 1984; 34(10B):1426-30. PubMed ID: 6097269
[TBL] [Abstract][Full Text] [Related]
5. Is tissue converting enzyme inhibition a determinant of the antihypertensive efficacy of converting enzyme inhibitors? Studies with the two different compounds, Hoe498 and MK421, in spontaneously hypertensive rats.
Unger T; Ganten D; Lang RE; Schölkens BA
J Cardiovasc Pharmacol; 1984; 6(5):872-80. PubMed ID: 6209494
[TBL] [Abstract][Full Text] [Related]
6. Persistent tissue converting enzyme inhibition following chronic treatment with Hoe498 and MK421 in spontaneously hypertensive rats.
Unger T; Ganten D; Lang RE; Schölkens BA
J Cardiovasc Pharmacol; 1985; 7(1):36-41. PubMed ID: 2580148
[TBL] [Abstract][Full Text] [Related]
7. Converting enzyme inhibitors and brain angiotensin.
Phillips MI; Kimura B
J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S82-90. PubMed ID: 2438497
[TBL] [Abstract][Full Text] [Related]
8. Effect of converting enzyme inhibitors on tissue converting enzyme and angiotensin II: therapeutic implications.
Unger T; Ganten D; Lang RE
Am J Cardiol; 1987 Apr; 59(10):18D-22D. PubMed ID: 3034027
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of the converting enzyme inhibitor, ramipril, in ischemic rat hearts.
Linz W; Schölkens BA; Han YF
J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S91-9. PubMed ID: 2438498
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular and antihypertensive activities of the novel non-sulfhydryl converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498).
Schölkens BA; Becker RH; Kaiser J
Arzneimittelforschung; 1984; 34(10B):1417-25. PubMed ID: 6097268
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of converting enzyme in the cerebrospinal fluid of rats after oral treatment with converting enzyme inhibitors.
Gohlke P; Urbach H; Schölkens B; Unger T
J Pharmacol Exp Ther; 1989 May; 249(2):609-16. PubMed ID: 2542535
[TBL] [Abstract][Full Text] [Related]
12. Renal tissue angiotensins during converting enzyme inhibition in the spontaneously hypertensive rat.
Grima M; Ingert C; Michel B; Barthelmebs M; Imbs JL
Clin Exp Hypertens; 1997; 19(5-6):671-85. PubMed ID: 9247747
[TBL] [Abstract][Full Text] [Related]
13. The renin-angiotensin system and ramipril, a new converting enzyme inhibitor.
Vasmant D; Bender N
J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S46-52. PubMed ID: 2483429
[TBL] [Abstract][Full Text] [Related]
14. Studies on the antihypertensive effect of single doses of the angiotensin converting enzyme inhibitor ramipril (HOE 498) in man.
Böhm RO; van Baak MA; Rahn KH
Eur J Clin Pharmacol; 1986; 30(5):541-7. PubMed ID: 3019702
[TBL] [Abstract][Full Text] [Related]
15. Converting enzyme inhibition and its withdrawal in spontaneously hypertensive rats.
Campbell DJ; Duncan AM; Kladis A; Harrap SB
J Cardiovasc Pharmacol; 1995 Sep; 26(3):426-36. PubMed ID: 8583785
[TBL] [Abstract][Full Text] [Related]
16. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
[TBL] [Abstract][Full Text] [Related]
17. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
Iimura O; Shimamoto K
Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
[TBL] [Abstract][Full Text] [Related]
18. [Antihypertensive effect of perindopril. Experimental pharmacology].
Barthelmebs M; Devissaguet M; Imbs JL
Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():17-24. PubMed ID: 2505709
[TBL] [Abstract][Full Text] [Related]
19. Role of the tissue renin-angiotensin system in the action of angiotensin-converting enzyme inhibitors.
Tokita Y; Oda H; Franco-Saenz R; Mulrow PJ
Proc Soc Exp Biol Med; 1995 Apr; 208(4):391-6. PubMed ID: 7700888
[TBL] [Abstract][Full Text] [Related]
20. The effects of perindopril on vascular smooth muscle polyploidy in stroke-prone spontaneously hypertensive rats.
Devlin AM; Gordon JF; Davidson AO; Clark JS; Hamilton CA; Morton JJ; Campbell AM; Reid JL; Dominiczak AF
J Hypertens; 1995 Feb; 13(2):211-8. PubMed ID: 7615951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
